Endothelium-derived hyperpolarizing factor mediates bradykinin-stimulated tissue plasminogen activator release in humans

Ayaz M. Rahman, Jonathan R. Murrow, Muhiddin A. Ozkor, Nino Kavtaradze, Ji Lin, Christine De Staercke, W. Craig Hooper, Amita Manatunga, Salim Hayek, Arshed A. Quyyumi

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Bradykinin (BK) stimulates tissue plasminogen activator (t-PA) release from human endothelium. Although BK stimulates both nitric oxide and endothelium-derived hyperpolarizing factor (EDHF) release, the role of EDHF in t-PA release remains unexplored. This study sought to determine the mechanisms of BK-stimulated t-PA release in the forearm vasculature of healthy human subjects. Methods: In 33 healthy subjects (age 40.3 ± 1.9 years), forearm blood flow (FBF) and t-PA release were measured at rest and after intra-arterial infusions of BK (400 ng/min) and sodium nitroprusside (3.2 mg/min). Measurements were repeated after intra-arterial infusion of tetraethylammonium chloride (TEA; 1 μmol/min), fluconazole (0.4 μmol·min-1·l-1), and NG-monomethyl-L-arginine (L-NMMA, 8 μmol/min) to block nitric oxide, and their combination in separate studies. Results: BK significantly increased net t-PA release across the forearm (p < 0.0001). Fluconazole attenuated both BK-mediated vasodilation (-23.3 ± 2.7% FBF, p < 0.0001) and t-PA release (from 50.9 ± 9.0 to 21.3 ± 8.9 ng/min/100 ml, p = 0.02). TEA attenuated FBF (-14.7 ± 3.2%, p = 0.002) and abolished BK-stimulated t-PA release (from 22.9 ± 5.7 to -0.8 ± 3.6 ng/min/100 ml, p = 0.0002). L-NMMA attenuated FBF (p < 0.0001), but did not inhibit BK-induced t-PA release (nonsignificant). Conclusion: BK-stimulated t-PA release is partly due to cytochrome P450-derived epoxides and is inhibited by K+Ca channel blockade. Thus, BK stimulates both EDHF-dependent vasodilation and t-PA release.

Original languageEnglish (US)
Pages (from-to)200-208
Number of pages9
JournalJournal of Vascular Research
Volume51
Issue number3
DOIs
StatePublished - Jan 1 2014

Fingerprint

Bradykinin
Tissue Plasminogen Activator
Endothelium
Forearm
omega-N-Methylarginine
Intra Arterial Infusions
Fluconazole
Vasodilation
Healthy Volunteers
Nitric Oxide
Tetraethylammonium
Epoxy Compounds
Nitroprusside
Cytochrome P-450 Enzyme System

Keywords

  • Bradykinin
  • Endothelium
  • Endothelium-derived hyperpolarizing factors
  • Fibrinolysis
  • Tissue plasminogen activator

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Endothelium-derived hyperpolarizing factor mediates bradykinin-stimulated tissue plasminogen activator release in humans. / Rahman, Ayaz M.; Murrow, Jonathan R.; Ozkor, Muhiddin A.; Kavtaradze, Nino; Lin, Ji; De Staercke, Christine; Hooper, W. Craig; Manatunga, Amita; Hayek, Salim; Quyyumi, Arshed A.

In: Journal of Vascular Research, Vol. 51, No. 3, 01.01.2014, p. 200-208.

Research output: Contribution to journalArticle

Rahman, AM, Murrow, JR, Ozkor, MA, Kavtaradze, N, Lin, J, De Staercke, C, Hooper, WC, Manatunga, A, Hayek, S & Quyyumi, AA 2014, 'Endothelium-derived hyperpolarizing factor mediates bradykinin-stimulated tissue plasminogen activator release in humans', Journal of Vascular Research, vol. 51, no. 3, pp. 200-208. https://doi.org/10.1159/000362666
Rahman, Ayaz M. ; Murrow, Jonathan R. ; Ozkor, Muhiddin A. ; Kavtaradze, Nino ; Lin, Ji ; De Staercke, Christine ; Hooper, W. Craig ; Manatunga, Amita ; Hayek, Salim ; Quyyumi, Arshed A. / Endothelium-derived hyperpolarizing factor mediates bradykinin-stimulated tissue plasminogen activator release in humans. In: Journal of Vascular Research. 2014 ; Vol. 51, No. 3. pp. 200-208.
@article{252fed5af62346c992c7a9d71a5d23b6,
title = "Endothelium-derived hyperpolarizing factor mediates bradykinin-stimulated tissue plasminogen activator release in humans",
abstract = "Bradykinin (BK) stimulates tissue plasminogen activator (t-PA) release from human endothelium. Although BK stimulates both nitric oxide and endothelium-derived hyperpolarizing factor (EDHF) release, the role of EDHF in t-PA release remains unexplored. This study sought to determine the mechanisms of BK-stimulated t-PA release in the forearm vasculature of healthy human subjects. Methods: In 33 healthy subjects (age 40.3 ± 1.9 years), forearm blood flow (FBF) and t-PA release were measured at rest and after intra-arterial infusions of BK (400 ng/min) and sodium nitroprusside (3.2 mg/min). Measurements were repeated after intra-arterial infusion of tetraethylammonium chloride (TEA; 1 μmol/min), fluconazole (0.4 μmol·min-1·l-1), and NG-monomethyl-L-arginine (L-NMMA, 8 μmol/min) to block nitric oxide, and their combination in separate studies. Results: BK significantly increased net t-PA release across the forearm (p < 0.0001). Fluconazole attenuated both BK-mediated vasodilation (-23.3 ± 2.7{\%} FBF, p < 0.0001) and t-PA release (from 50.9 ± 9.0 to 21.3 ± 8.9 ng/min/100 ml, p = 0.02). TEA attenuated FBF (-14.7 ± 3.2{\%}, p = 0.002) and abolished BK-stimulated t-PA release (from 22.9 ± 5.7 to -0.8 ± 3.6 ng/min/100 ml, p = 0.0002). L-NMMA attenuated FBF (p < 0.0001), but did not inhibit BK-induced t-PA release (nonsignificant). Conclusion: BK-stimulated t-PA release is partly due to cytochrome P450-derived epoxides and is inhibited by K+Ca channel blockade. Thus, BK stimulates both EDHF-dependent vasodilation and t-PA release.",
keywords = "Bradykinin, Endothelium, Endothelium-derived hyperpolarizing factors, Fibrinolysis, Tissue plasminogen activator",
author = "Rahman, {Ayaz M.} and Murrow, {Jonathan R.} and Ozkor, {Muhiddin A.} and Nino Kavtaradze and Ji Lin and {De Staercke}, Christine and Hooper, {W. Craig} and Amita Manatunga and Salim Hayek and Quyyumi, {Arshed A.}",
year = "2014",
month = "1",
day = "1",
doi = "10.1159/000362666",
language = "English (US)",
volume = "51",
pages = "200--208",
journal = "Journal of Vascular Research",
issn = "1018-1172",
publisher = "S. Karger AG",
number = "3",

}

TY - JOUR

T1 - Endothelium-derived hyperpolarizing factor mediates bradykinin-stimulated tissue plasminogen activator release in humans

AU - Rahman, Ayaz M.

AU - Murrow, Jonathan R.

AU - Ozkor, Muhiddin A.

AU - Kavtaradze, Nino

AU - Lin, Ji

AU - De Staercke, Christine

AU - Hooper, W. Craig

AU - Manatunga, Amita

AU - Hayek, Salim

AU - Quyyumi, Arshed A.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Bradykinin (BK) stimulates tissue plasminogen activator (t-PA) release from human endothelium. Although BK stimulates both nitric oxide and endothelium-derived hyperpolarizing factor (EDHF) release, the role of EDHF in t-PA release remains unexplored. This study sought to determine the mechanisms of BK-stimulated t-PA release in the forearm vasculature of healthy human subjects. Methods: In 33 healthy subjects (age 40.3 ± 1.9 years), forearm blood flow (FBF) and t-PA release were measured at rest and after intra-arterial infusions of BK (400 ng/min) and sodium nitroprusside (3.2 mg/min). Measurements were repeated after intra-arterial infusion of tetraethylammonium chloride (TEA; 1 μmol/min), fluconazole (0.4 μmol·min-1·l-1), and NG-monomethyl-L-arginine (L-NMMA, 8 μmol/min) to block nitric oxide, and their combination in separate studies. Results: BK significantly increased net t-PA release across the forearm (p < 0.0001). Fluconazole attenuated both BK-mediated vasodilation (-23.3 ± 2.7% FBF, p < 0.0001) and t-PA release (from 50.9 ± 9.0 to 21.3 ± 8.9 ng/min/100 ml, p = 0.02). TEA attenuated FBF (-14.7 ± 3.2%, p = 0.002) and abolished BK-stimulated t-PA release (from 22.9 ± 5.7 to -0.8 ± 3.6 ng/min/100 ml, p = 0.0002). L-NMMA attenuated FBF (p < 0.0001), but did not inhibit BK-induced t-PA release (nonsignificant). Conclusion: BK-stimulated t-PA release is partly due to cytochrome P450-derived epoxides and is inhibited by K+Ca channel blockade. Thus, BK stimulates both EDHF-dependent vasodilation and t-PA release.

AB - Bradykinin (BK) stimulates tissue plasminogen activator (t-PA) release from human endothelium. Although BK stimulates both nitric oxide and endothelium-derived hyperpolarizing factor (EDHF) release, the role of EDHF in t-PA release remains unexplored. This study sought to determine the mechanisms of BK-stimulated t-PA release in the forearm vasculature of healthy human subjects. Methods: In 33 healthy subjects (age 40.3 ± 1.9 years), forearm blood flow (FBF) and t-PA release were measured at rest and after intra-arterial infusions of BK (400 ng/min) and sodium nitroprusside (3.2 mg/min). Measurements were repeated after intra-arterial infusion of tetraethylammonium chloride (TEA; 1 μmol/min), fluconazole (0.4 μmol·min-1·l-1), and NG-monomethyl-L-arginine (L-NMMA, 8 μmol/min) to block nitric oxide, and their combination in separate studies. Results: BK significantly increased net t-PA release across the forearm (p < 0.0001). Fluconazole attenuated both BK-mediated vasodilation (-23.3 ± 2.7% FBF, p < 0.0001) and t-PA release (from 50.9 ± 9.0 to 21.3 ± 8.9 ng/min/100 ml, p = 0.02). TEA attenuated FBF (-14.7 ± 3.2%, p = 0.002) and abolished BK-stimulated t-PA release (from 22.9 ± 5.7 to -0.8 ± 3.6 ng/min/100 ml, p = 0.0002). L-NMMA attenuated FBF (p < 0.0001), but did not inhibit BK-induced t-PA release (nonsignificant). Conclusion: BK-stimulated t-PA release is partly due to cytochrome P450-derived epoxides and is inhibited by K+Ca channel blockade. Thus, BK stimulates both EDHF-dependent vasodilation and t-PA release.

KW - Bradykinin

KW - Endothelium

KW - Endothelium-derived hyperpolarizing factors

KW - Fibrinolysis

KW - Tissue plasminogen activator

UR - http://www.scopus.com/inward/record.url?scp=84902032222&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902032222&partnerID=8YFLogxK

U2 - 10.1159/000362666

DO - 10.1159/000362666

M3 - Article

C2 - 24925526

AN - SCOPUS:84902032222

VL - 51

SP - 200

EP - 208

JO - Journal of Vascular Research

JF - Journal of Vascular Research

SN - 1018-1172

IS - 3

ER -